Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples